Selective pharma, FMCG and consumer durable and banking stocks were in demand, while capital goods, refinery, auto and power stocks registered losses.
The 30-share index Sensex resumed the day lower in line with weak Asian trends and moved erratically before settling at 21,856.22, up by 29.80 points from its previous close.
Yesterday, it had snapped five days of gains by ending 108 points lower.
Meanwhile, foreign institutional investors (FIIs) bought shares worth net Rs 1,471.23 crore yesterday, as per provisional data from stock exchanges.
Pharmaceuticals major, Sun Pharma, was the top Sensex gainer of the day at 4.08 per cent as its subsidiary Caraco has received approval from US Food and Drug Administration (FDA) for Risperidone oral tablets.
FMCG and cigarettes giant ITC rose 2.08 per cent and emerged as the biggest contributor to the Sensex gain.
"Markets were seen ending on flat note as investors preferred to sit on sidelines ahead of IIP data and CPI inflation figure, which is due post market today," Jayant Manglik, President-retail distribution, Religare Securities Limited, said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
